We are live on ! Find out more
NUVB icon

Nuvation Bio
NUVB

105 hedge funds and large institutions have $1.32B invested in Nuvation Bio in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 48 increasing their positions, 26 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

199% more call options, than puts

Call options by funds: $371K | Put options by funds: $124K

85% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 26

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

7% more funds holding

Funds holding: 98 → 105 (+7)

1.87% more ownership

Funds ownership: 69.47% → 71.35% (+1.9%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

12% less capital invested

Capital invested by funds: $1.5B → $1.32B (-$184M)

Holders
105
Holders Change
+7
Holders Change %
+7.14%
% of All Funds
1.62%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
17
Increased
48
Reduced
26
Closed
10
Calls
$371K
Puts
$124K
Net Calls
+$247K
Net Calls Change
+$101K

Top Buyers

1
BlackRock
BlackRock
New York
+$49.6M
2
State Street
State Street
Massachusetts
+$12.2M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$6.88M
4
Northern Trust
Northern Trust
Illinois
+$6.15M
5
JP Morgan Chase
JP Morgan Chase
New York
+$5.7M

Top Sellers

1
OFM
Omega Fund Management
Massachusetts
-$48.3M
2
RG
Redmile Group
California
-$8M
3
FCM
Farallon Capital Management
California
-$7.17M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$5.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$269M -$4.27M -464,134 -1%
OFM
2
Omega Fund Management
Massachusetts
$195M -$48.3M -5,255,036 -19%
EC
3
EcoR1 Capital
California
$118M +$1.7M +185,026 +1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$95.7M -$5.9M -641,975 -5%
BlackRock
5
BlackRock
New York
$91.8M +$49.6M +5,397,329 +100%
BG
6
Baupost Group
Massachusetts
$73M – – –
APM
7
Avidity Partners Management
Texas
$62.8M +$1.09M +119,000 +2%
Citadel Advisors
8
Citadel Advisors
Florida
$46.8M -$1.3M -141,018 -2%
BC
9
Boxer Capital
California
$36.9M – – –
ACM
10
Abrams Capital Management
Massachusetts
$32.4M – – –
RG
11
Redmile Group
California
$31.2M -$8M -870,000 -19%
DM
12
Deerfield Management
New York
$30.4M – – –
PA
13
Perceptive Advisors
New York
$24.8M -$1.1M -120,181 -4%
State Street
14
State Street
Massachusetts
$23.2M +$12.2M +1,330,900 +95%
ACM
15
Aisling Capital Management
New York
$21.6M – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$18.3M +$6.88M +748,225 +53%
FCM
17
Farallon Capital Management
California
$12.2M -$7.17M -780,000 -35%
Northern Trust
18
Northern Trust
Illinois
$12M +$6.15M +669,667 +90%
EPL
19
EDBI Pte Ltd
Singapore
$10.8M +$11.7M +1,270,504 New
ABG
20
Ally Bridge Group
New York
$10.2M -$4.26M -463,795 -28%
Ensign Peak Advisors
21
Ensign Peak Advisors
Utah
$9.84M -$598K -65,110 -5%
Charles Schwab
22
Charles Schwab
California
$7.72M +$1.95M +212,255 +31%
N
23
Nuveen
North Carolina
$6.23M +$2.83M +307,748 +72%
Ameriprise
24
Ameriprise
Minnesota
$6.19M +$1.1K +120 +0%
AIC
25
AWM Investment Company
New York
$5.95M +$2.76M +300,000 +75%
1
2 3 4 5

NUVB Hedge Fund Activity: Q4 2021 in Review

105 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q4 2021, worth a combined $1.32B — down 12% from $1.5B a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new NUVB positions and 10 closed out — a net gain of 7 holders — while 48 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $49.6M. The largest seller was Omega Fund Management, cutting an estimated $48.3M.

  • 105 institutional investors held Nuvation Bio (NUVB) as of Q4 2021, up from 98 in Q3 2021.
  • Funds reported $1.32B of Nuvation Bio stock for Q4 2021, down 12% quarter-over-quarter.
  • 17 funds opened new Nuvation Bio positions in Q4 2021 and 10 closed out, a net change of +7 holders.
  • The largest Nuvation Bio buyer in Q4 2021 was BlackRock, an estimated $49.6M added.
  • The largest Nuvation Bio seller in Q4 2021 was Omega Fund Management, an estimated $48.3M sold.

Based on aggregated 13F filings for Q4 2021.